Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Rocon who wrote (11278)	7/12/1998 1:04:00 PM
From: EyeDrMike	Read Replies (3) \| Respond to of 23519

<< If the unaudited international sales of $9,841,000 were solely for the UK, as you noted that..and with 4 production lines geared up and running in Lakewood, the 3rd quarter should reflect strong results. This will make a solid case for a strong suitor like J&J or Astra. I look for positive developments (all around) by the end of July.>> I was thinking the same thing myself. Although MUSE has been approved in many countries, it is actually only being marketed and sold in one or two. I believe the holdup had to do with FDA approval of the new plant, and concerns on the part of Astra that there would be an unrestricted supply of product. Four lines running now, and could see all eight up and running by end of Q. mike